Icvrx's Seed Round

Icvrx raised a round of funding on January 18, 2011.

ICVrx is an early stage company that is developing a novel method of treating serious diseases of the Central Nervous System (CNS), including refractory epilepsy.…

Articles about Icvrx's Seed Round: